Evidence map›Paper›PMID 37264933›Full record

ArticleNucleic acids research2023

Mechanistic insight into AP-endonuclease 1 cleavage of abasic sites at stalled replication fork mimics.

Nicole M Hoitsma, Jessica Norris, Thu H Khoang, Vikas Kaushik, Rahul Chadda, Edwin Antony, Mark Hedglin, Bret D Freudenthal

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Nanoscale Interaction of Endonuclease APE1 with DNA.International journal of molecular sciences · 2024
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicole M HoitsmaDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Jessica NorrisDepartment of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA.
Thu H KhoangDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Vikas KaushikDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
Rahul ChaddaDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.
Edwin AntonyDepartment of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA.ORCID 0000-0002-1888-054X
Mark HedglinDepartment of Chemistry, The Pennsylvania State University, University Park, PA 16802, USA.ORCID 0000-0003-2599-1691
Bret D FreudenthalDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.ORCID 0000-0003-1449-4710
Saint Louis University · USUniversity of Kansas Medical Center · USPennsylvania State University · US

Funding

Deciphering the progression and regulation of human translesion DNA synthesisR35GM147238 · NIGMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Mark Hedglin · 2022 to 2026
$2.0M
APE1 Cleavage Mechanisms during DNA RepairR01ES029203 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FREUDENTHAL, BRET D · 2018 to 2022
$1.9M
Supplement Request for a FluorometerR01GM133967 · NIGMS · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2019 to 2023
$1.5M
Mechanisms of DNA hand-off during lesion repair in BER and NER supplementR01GM130746 · NIGMS · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2019 to 2022
$1.4M
Acquisition of an Optima Analytical UltracentrifugeS10OD030343 · OD · SAINT LOUIS UNIVERSITY · PI ANTONY, EDWIN · 2021 to 2021
$515k
NIEHS NIH HHS R01 ES029203NIGMS NIH HHS R01 GM130746NIGMS NIH HHS R01 GM133967NIGMS NIH HHS R35 GM147238NIH HHS S10 OD030343
6 · The paper itself

Abstract

Many types of damage, including abasic sites, block replicative DNA polymerases causing replication fork uncoupling and generating ssDNA. AP-Endonuclease 1 (APE1) has been shown to cleave abasic sites in ssDNA. Importantly, APE1 cleavage of ssDNA at a replication fork has significant biological implications by generating double strand breaks that could collapse the replication fork. Despite this, the molecular basis and efficiency of APE1 processing abasic sites at replication forks remain elusive. Here, we investigate APE1 cleavage of abasic substrates that mimic APE1 interactions at stalled replication forks or gaps. We determine that APE1 has robust activity on these substrates, like dsDNA, and report rates for cleavage and product release. X-ray structures visualize the APE1 active site, highlighting an analogous mechanism is used to process ssDNA substrates as canonical APE1 activity on dsDNA. However, mutational analysis reveals R177 to be uniquely critical for the APE1 ssDNA cleavage mechanism. Additionally, we investigate the interplay between APE1 and Replication Protein A (RPA), the major ssDNA-binding protein at replication forks, revealing that APE1 can cleave an abasic site while RPA is still bound to the DNA. Together, this work provides molecular level insights into abasic ssDNA processing by APE1, including the presence of RPA.

Indexed as

DNA-(Apurinic or Apyrimidinic Site) LyaseDNA ReplicationDNADNA DamageDNA RepairDNA, Single-StrandedEndonucleasesReplication Protein AAPEX1 protein, humanDNADNA-(Apurinic or Apyrimidinic Site) LyaseDNA, Single-StrandedEndonucleasesReplication Protein A

Identifiers

PMID37264933
PMCPMC10359615
OpenAlexW4379094082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.